Embong, Julito B.

HRN: 26-68-68  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/13/2025
CEFTRIAXONE 1G (VIAL)
02/13/2025
02/19/2025
IV
2g
OD
CAP MR
Waiting Final Action 
02/13/2025
AZITHROMYCIN 500MG TABLET (TAB)
02/13/2025
02/17/2025
ORAL
500 Mg
OD
CAP MR
Waiting Final Action 
02/14/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
02/14/2025
02/21/2025
IV
2.25g
Q8
CAP MR
Rejected 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: